Skip to content

Current ratio at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
1.4×-0.4×
United Therapeutics logo
United TherapeuticsUTHR
4.8×-0.7×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
2.1×-1.1×
Arrowhead Research logo
Arrowhead ResearchARWR
6.2×+1.1×
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
4.1×-5.6×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.0×

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$6.32B+164%
Enterprise value$6.1B+184%
P/S21.9×-147×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×

Where this comes from

Calculated from Liquidia Corporation’s reported figures.

Based on the most recent quarter.

The official record: Liquidia Corporation’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Liquidia Corporation's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Liquidia Corporation's current ratio?
Liquidia Corporation (LQDA) reported current ratio of 2.2× in Q1 2026.
How has Liquidia Corporation's current ratio changed year-over-year?
Liquidia Corporation's current ratio decreased by 24.0% year-over-year, from 2.9× to 2.2×.
What is the long-term trend for Liquidia Corporation's current ratio?
Over 5 years (2020 to 2025), Liquidia Corporation's current ratio has grown at a -18.6% compound annual growth rate (CAGR), from 5.6× to 2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.